BioXcel Files for Chapter 11 as Teva Offers $57.5 Million Stalking-Horse Bid for Igalmi

BioXcel seeks Chapter 11 with a $19M DIP loan as Teva offers $57.5M plus milestones for Igalmi. Auction still open; sale not closed.